Lyngby, Denmark

Tomas Norling

USPTO Granted Patents = 22 

 

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 585(Granted Patents)


Company Filing History:


Years Active: 1999-2024

Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Tomas Norling and His Contributions to Transplant Medicine

Introduction: Tomas Norling, a renowned inventor based in Lyngby, Denmark, holds an impressive portfolio of 22 patents in the pharmaceutical field. His groundbreaking work focuses on innovations that significantly enhance treatments for transplant patients, making him a prominent figure in the medical community.

Latest Patents: Among his latest patents is a revolutionary formulation for tacrolimus, an essential immunosuppressive medication used primarily for kidney and liver transplant patients. Norling's patent details an extended-release oral dosage form that allows for once-daily administration. This innovative dosage form ensures a prolonged and consistent release of the active substance, resulting in improved pharmacokinetic parameters. Compared to conventional immediate-release dosage forms, his formulation exhibits lower peak concentrations, increased bioavailability, extended times to reach maximal concentration, and higher minimum concentrations. These advancements aim to optimize patient outcomes and enhance the overall effectiveness of transplant treatments.

Career Highlights: Tomas Norling's career is marked by significant contributions to the pharmaceutical industry, particularly during his tenure at Veloxis Pharmaceuticals A/S and Veloxis Pharmaceuticals Inc. His expertise in drug formulation and innovation has played a pivotal role in advancing therapeutic options for transplant patients, thereby improving their quality of life.

Collaborations: Throughout his career, Norling has collaborated with notable professionals in the field, including Per Holm and Robert D. Gordon. These partnerships have fostered a rich environment for research and development, leading to significant advancements in transplant medicine.

Conclusion: Tomas Norling's commitment to innovation in pharmaceutical sciences, particularly concerning transplant treatments, showcases the vital role inventors play in healthcare. His work not only advances medical science but also offers hope and improved outcomes for countless patients in need of transplants. As he continues to develop impactful medications, his legacy will undoubtedly inspire future generations of inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…